A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer

Summary

This research study is studying a targeted therapy as a possible treatment for thyroid cancer. A targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. \- The name of the study intervention involved in this study is regorafenib.

Timeline

Start

2016-01

Primary completion

2025-12

Completion

2025-12

Publications

• Ettrich TJ, Seufferlein T. Regorafenib. Recent Results Cancer Res. 2018;211:45-56. doi: 10.1007/978-3-319-91442-8_3.

Drugs

Indications